Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,628 | 258 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $702.30 | 37 | $0 (2024) |
| Biogen, Inc. | $482.51 | 25 | $0 (2024) |
| PFIZER INC. | $413.31 | 33 | $0 (2024) |
| Eisai Inc. | $282.47 | 14 | $0 (2024) |
| SK Life Science, Inc. | $249.29 | 14 | $0 (2024) |
| Lundbeck LLC | $224.65 | 15 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $222.86 | 6 | $0 (2021) |
| Lilly USA, LLC | $201.83 | 11 | $0 (2024) |
| Amgen Inc. | $197.02 | 10 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $189.05 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,289 | 80 | PFIZER INC. ($237.25) |
| 2023 | $693.60 | 39 | ABBVIE INC. ($201.13) |
| 2022 | $1,364 | 77 | Biogen, Inc. ($254.43) |
| 2021 | $1,281 | 62 | Biohaven Pharmaceuticals, Inc. ($222.86) |
All Payment Transactions
258 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $10.68 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.19 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: Neuroscience | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: PAIN | ||||||
| 12/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Central Nervous System | ||||||
| 12/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Neuropsychiatry | ||||||
| 12/02/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: PAIN | ||||||
| 11/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.58 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $14.44 | General |
| Category: NEUROLOGY | ||||||
| 11/11/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 11/11/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: EPILEPSY | ||||||
| 11/07/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Neurology | ||||||
| 11/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: PAIN | ||||||
| 10/29/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: Neurology | ||||||
| 10/15/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Neuroscience | ||||||
| 10/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $3.33 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.01 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: PAIN | ||||||
| 10/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: NEUROLOGY | ||||||
| 09/27/2024 | Cycle Pharmaceuticals Inc | Tascenso ODT (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: NEUROLOGY | ||||||
| 09/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.08 | General |
| Category: PAIN | ||||||
| 09/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $11.37 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 191 | 245 | $45,954 | $14,466 |
| 2022 | 8 | 271 | 377 | $67,518 | $25,316 |
| 2021 | 6 | 190 | 258 | $37,865 | $14,587 |
| 2020 | 8 | 265 | 360 | $44,849 | $18,197 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 97 | 148 | $27,880 | $8,444 | 30.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 19 | $5,624 | $1,916 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 46 | 48 | $6,396 | $1,766 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $3,912 | $1,307 | 33.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 14 | $2,142 | $1,033 | 48.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 89 | 143 | $26,008 | $8,932 | 34.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 36 | 36 | $10,530 | $4,635 | 44.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 35 | 70 | $7,398 | $3,301 | 44.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 28 | 37 | $5,601 | $2,494 | 44.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 17 | 19 | $4,868 | $1,835 | 37.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 20 | 20 | $4,690 | $1,474 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 35 | 41 | $5,230 | $1,422 | 27.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $3,193 | $1,223 | 38.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 69 | 115 | $19,996 | $7,320 | 36.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 41 | 50 | $6,080 | $1,998 | 32.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 27 | 37 | $3,785 | $1,773 | 46.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 17 | 17 | $4,188 | $1,675 | 40.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 19 | 19 | $2,761 | $1,308 | 47.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 17 | 20 | $1,055 | $512.40 | 48.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 36 | 36 | $9,672 | $4,750 | 49.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 78 | 110 | $15,249 | $4,657 | 30.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 55 | 95 | $9,390 | $4,629 | 49.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 27 | 41 | $2,122 | $1,092 | 51.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 32 | 37 | $3,430 | $973.42 | 28.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 11 | 12 | $1,690 | $844.62 | 50.0% |
About Beth Earles
Beth Earles is a Family healthcare provider based in Salem, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2019. The National Provider Identifier (NPI) number assigned to this provider is 1225680127.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Beth Earles has received a total of $4,628 in payments from pharmaceutical and medical device companies, with $1,289 received in 2024. These payments were reported across 258 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,628).
As a Medicare-enrolled provider, Earles has provided services to 917 Medicare beneficiaries, totaling 1,240 services with total Medicare billing of $72,566. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Salem, OH
- Active Since 07/10/2019
- Last Updated 12/06/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1225680127
Products in Payments
- NURTEC ODT (Drug) $746.98
- UBRELVY (Drug) $345.79
- QULIPTA (Drug) $338.72
- VUMERITY (Drug) $241.30
- Aimovig (Biological) $197.02
- AUBAGIO (Drug) $185.27
- EMGALITY (Drug) $176.00
- Leqembi (Drug) $163.85
- Briviact (Drug) $121.31
- VALTOCO (Drug) $120.96
- Fycompa (Drug) $118.62
- TYSABRI (Biological) $117.56
- VYEPTI (Biological) $114.50
- REXULTI (Drug) $110.15
- BAFIERTAM (Drug) $106.12
- Soliris (Drug) $92.70
- Dhivy (Drug) $71.34
- Austedo XR (Drug) $70.87
- ULTOMIRIS (Biological) $66.21
- PANZYGA (Biological) $62.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Salem
Dr. Christopher Gessel, Np, NP
Family — Payments: $19,312
Pamela Price, Np, NP
Family — Payments: $15,044
Neeta Vorst, Fnp, FNP
Family — Payments: $14,287
Mrs. Kelli Farm, Np, NP
Family — Payments: $12,377
Mrs. Kelly Link, Np-C, NP-C
Family — Payments: $8,038
Mrs. Beth Hite, Np-C, NP-C
Family — Payments: $6,450